Sectors & Industries HealthcareBiotechnology
Best Biotech Stocks to Buy Now (2026)
Top biotech stocks in 2026 ranked by overall Zen Rating. "A" Rated stocks have returned an average of +32.52% per year, and are the best biotech stocks to buy now. Learn More.

Industry: Biotechnology

Overview Zen Rating Price Value Growth Financials

Momentum Sentiment Forecast Dividends Due Diligence

Biotech is Zen Rated F and is the 135th ranked industry out of 145 stock market industries

Ticker	Company	Market Cap	ROE	ROA	ROCE	ROIC	D/E	Current Ratio	Gross Margin	Profit Margin	Operating Margin
NTLA	INTELLIA THERAPEUTICS INC	$1.42B	-57.20%	-44.60%	-53.61%	-51.60%	0.24	6.21	100.00%	-774.90%	-774.94%
TARA	PROTARA THERAPEUTICS INC	$256.61M	-35.10%	-32.50%	-39.27%	-63.70%	0.09	13.69	N/A	N/A	N/A
ENVB	ENVERIC BIOSCIENCES INC	$1.41M	-403.40%	-279.50%	-281.40%	1,913.00%	0.26	4.60	N/A	N/A	N/A
ACTU	ACTUATE THERAPEUTICS INC	$102.50M	-2,924.50%	-250.70%	-212.50%	311.00%	0.62	2.74	N/A	N/A	N/A
DSGN	DESIGN THERAPEUTICS INC	$585.02M	-30.60%	-29.20%	-33.62%	-32.80%	0.06	18.71	N/A	N/A	N/A
AVXL	ANAVEX LIFE SCIENCES CORP	$366.33M	-46.80%	-41.50%	-48.89%	423.70%	0.09	11.61	N/A	N/A	N/A
DCOY	DECOY THERAPEUTICS INC	$4.57M	-401.00%	-155.80%	-117.81%	443.70%	0.44	3.28	N/A	N/A	N/A
DRTS	ALPHA TAU MEDICAL LTD	$604.66M	-51.20%	-38.20%	-31.98%	-37.50%	0.28	10.52	N/A	N/A	N/A
QURE	UNIQURE NV	$1.60B	-373.70%	-35.70%	-20.62%	-22.70%	2.88	7.12	88.10%	-1,492.90%	-1,031.34%
TSHA	TAYSHA GENE THERAPIES INC	$1.26B	-67.30%	-42.10%	-34.68%	-185.10%	0.45	10.48	100.00%	-1,583.70%	-1,582.50%
GHRS	GH RESEARCH PLC	$940.68M	-15.80%	-15.30%	-14.53%	-71.20%	0.04	28.32	N/A	N/A	N/A
CBIO	CRESCENT BIOPHARMA INC	$132.12M	-84.60%	-71.60%	-46.53%	693.40%	0.19	6.63	N/A	N/A	N/A
YDES	YD BIOPHARMA LTD	$790.68M	N/A	-12.30%	-20.99%	401.50%	0.04	13.18	30.40%	-276.60%	-271.52%
HURA	TUHURA BIOSCIENCES INC	$32.24M	-221.90%	-141.90%	-178.58%	-2,355.40%	0.53	0.40	N/A	N/A	N/A
HUMA	HUMACYTE INC	$175.66M	N/A	-27.90%	-39.90%	-24.80%	-20.26	1.62	60.50%	-2,353.20%	-1,674.35%
GOSS	GOSSAMER BIO INC	$523.09M	N/A	-59.70%	-100.61%	-38.50%	-3.54	3.28	100.00%	-354.50%	-335.05%
DYN	DYNE THERAPEUTICS INC	$2.40B	-66.20%	-56.30%	-52.13%	-146.40%	0.25	13.47	N/A	N/A	N/A
AIXC	AIXCRYPTO HOLDINGS INC	$7.33M	-90.50%	-65.20%	-19.08%	-420.70%	0.13	8.83	N/A	N/A	N/A
ADTX	ADITXT INC	$364.20k	-757.20%	-156.60%	472.06%	-351.20%	-2.67	0.02	-1,111.20%	-710,498.70%	-703,444.47%
TERN	TERNS PHARMACEUTICALS INC	$3.40B	-30.00%	-28.50%	-32.91%	-55.60%	0.06	19.52	N/A	N/A	N/A
OVID	OVID THERAPEUTICS INC	$113.94M	-63.70%	-46.10%	-63.68%	-62.50%	0.43	4.24	100.00%	-549.60%	-549.62%
AURA	AURA BIOSCIENCES INC	$355.62M	-69.70%	-58.20%	-62.12%	-82.20%	0.21	9.04	N/A	N/A	N/A
STRO	SUTRO BIOPHARMA INC	$132.13M	N/A	-73.40%	-155.14%	-202.80%	-3.40	2.53	100.00%	-205.20%	-202.30%
CHRS	COHERUS ONCOLOGY INC	$258.66M	-574.70%	34.90%	115.84%	139.50%	4.89	1.24	47.80%	185.40%	199.92%
FBRX	FORTE BIOSCIENCES INC	$345.62M	-75.60%	-65.90%	-61.53%	-3,473.20%	0.15	7.34	N/A	N/A	N/A
OKUR	ONKURE THERAPEUTICS INC	$33.87M	-95.80%	-86.90%	-121.50%	1,899.00%	0.10	11.45	N/A	N/A	N/A
FDMT	4D MOLECULAR THERAPEUTICS INC	$513.64M	-47.30%	-42.40%	-54.07%	-54.60%	0.15	8.42	100.00%	-174,314.20%	-174,314.17%
ABVX	ABIVAX SA	$8.58B	N/A	N/A	N/A	N/A	0.28	7.86	N/A	N/A	N/A
NUVL	NUVALENT INC	$7.53B	-39.50%	-35.70%	-42.75%	-44.00%	0.16	10.73	N/A	N/A	N/A
SPRB	SPRUCE BIOSCIENCES INC	$77.49M	-305.40%	-168.00%	-762.62%	955.90%	1.84	1.54	100.00%	-6,869.30%	-6,440.17%
XFOR	X4 PHARMACEUTICALS INC	$311.27M	-343.70%	-69.80%	-61.27%	-78.30%	1.65	5.65	83.20%	-279.90%	-252.51%
PMCB	PHARMACYTE BIOTECH INC	$7.51M	-25.80%	-22.10%	-13.00%	-22.30%	0.55	14.60	N/A	N/A	N/A
VTVT	VTV THERAPEUTICS INC	$114.28M	-100.50%	-47.80%	-26.27%	463.90%	0.41	9.79	100.00%	-138,058.80%	-138,029.41%
ATAI	ATAI BECKLEY NV	$1.37B	-107.90%	-78.60%	-68.03%	-104.70%	0.50	7.90	100.00%	-5,109.10%	-5,032.77%
TENX	TENAX THERAPEUTICS INC	$79.48M	-43.20%	-41.50%	-45.03%	1,681.90%	0.07	15.58	N/A	N/A	N/A
CELC	CELCUITY INC	$4.94B	-179.00%	-58.00%	-33.96%	-41.30%	3.07	12.26	N/A	N/A	N/A
IMRX	IMMUNEERING CORP	$318.33M	-73.50%	-65.00%	-26.99%	-1,472.40%	0.06	24.00	N/A	N/A	N/A
RAPP	RAPPORT THERAPEUTICS INC	$1.29B	-28.60%	-27.20%	-18.75%	-38.90%	0.05	36.37	N/A	N/A	N/A
SRPT	SAREPTA THERAPEUTICS INC	$1.94B	-20.30%	-7.40%	-9.81%	-7.10%	1.65	2.95	76.30%	-11.20%	-10.45%
ZURA	ZURA BIO LTD	$390.79M	-48.20%	-38.30%	-54.26%	359.10%	0.24	5.58	N/A	N/A	N/A
OABI	OMNIAB INC	$244.72M	-23.10%	-20.60%	-22.59%	-84.50%	0.12	5.00	98.60%	-301.80%	-317.49%
SRZN	SURROZEN INC	$195.43M	-5,313.30%	-116.50%	-119.80%	-835.10%	-5.00	13.15	100.00%	-6,400.70%	-6,400.73%
MRVI	MARAVAI LIFESCIENCES HOLDINGS INC	$802.92M	-42.60%	-13.10%	-11.90%	-16.40%	1.70	5.29	20.90%	-63.10%	-48.76%
APGE	APOGEE THERAPEUTICS INC	$4.25B	-39.10%	-36.90%	-42.80%	-46.30%	0.07	15.86	N/A	N/A	N/A
TRDA	ENTRADA THERAPEUTICS INC	$405.12M	-26.40%	-22.10%	-26.87%	-25.40%	0.21	14.08	100.00%	-168.20%	-169.85%
ORIC	ORIC PHARMACEUTICALS INC	$1.01B	-45.30%	-41.80%	-32.91%	-55.20%	0.06	14.65	N/A	N/A	N/A
AMLX	AMYLYX PHARMACEUTICALS INC	$1.54B	-68.90%	-61.50%	-44.49%	-128.50%	0.09	13.70	100.00%	22,448.40%	22,543.91%
PYXS	PYXIS ONCOLOGY INC	$94.02M	-102.10%	-74.40%	-114.78%	-85.40%	0.54	4.29	100.00%	-3,442.80%	-3,509.47%
CVKD	CADRENAL THERAPEUTICS INC	$11.83M	-279.50%	-204.50%	-525.99%	928.40%	0.50	3.02	N/A	N/A	N/A
ANVS	ANNOVIS BIO INC	$65.99M	-153.50%	-125.50%	-184.94%	-8,454.30%	0.31	4.60	N/A	N/A	N/A
ABEO	ABEONA THERAPEUTICS INC	$278.00M	78.40%	48.00%	41.45%	86.10%	0.35	9.74	-22.00%	20,587.50%	21,650.75%
DMAC	DIAMEDICA THERAPEUTICS INC	$423.91M	-83.30%	-73.60%	-61.70%	-90.10%	0.11	10.67	N/A	N/A	N/A
RVMD	REVOLUTION MEDICINES INC	$18.85B	-49.20%	-40.00%	-47.32%	-46.80%	0.41	8.05	N/A	N/A	N/A
REPL	REPLIMUNE GROUP INC	$639.94M	-102.70%	-72.20%	-108.40%	-88.80%	0.58	5.60	N/A	N/A	N/A
LEXX	LEXARIA BIOSCIENCE CORP	$18.04M	-209.60%	-168.30%	-234.89%	-4,098.00%	0.31	3.68	100.00%	-2,067.70%	-2,067.31%
INMB	INMUNE BIO INC	$40.14M	-172.00%	-134.50%	-191.87%	1,346.60%	0.31	4.17	100.00%	-99,774.00%	-99,774.00%
VERU	VERU INC	$37.56M	-111.70%	-70.10%	-103.06%	-786.10%	0.63	2.43	N/A	N/A	N/A
ANNX	ANNEXON INC	$685.50M	-93.10%	-72.90%	-111.57%	-120.40%	0.42	4.43	N/A	N/A	N/A
NMRA	NEUMORA THERAPEUTICS INC	$354.23M	-113.80%	-96.90%	-154.89%	-242.80%	0.35	6.85	N/A	N/A	N/A
OMER	OMEROS CORP	$796.21M	N/A	-53.90%	-121.65%	-23.80%	-1.84	0.89	N/A	N/A	N/A
VSTM	VERASTEM INC	$445.40M	N/A	-159.10%	-204.07%	-526.30%	-12.39	2.58	82.00%	-1,802.10%	-1,786.77%
WHWK	WHITEHAWK THERAPEUTICS INC	$130.07M	-10.40%	-9.60%	-9.94%	-37.60%	0.06	16.76	89.20%	-108.60%	-108.58%
TLX	TELIX PHARMACEUTICALS LTD	$2.38B	13.90%	5.20%	7.84%	27.90%	1.67	2.78	65.10%	6.40%	11.87%
RNAC	CARTESIAN THERAPEUTICS INC	$168.76M	N/A	-12.60%	-13.29%	-27.00%	-11.40	10.67	100.00%	-4,638.60%	-4,371.40%
KRRO	KORRO BIO INC	$118.38M	-68.90%	-45.90%	-60.11%	-49.60%	0.63	6.71	100.00%	-1,199.50%	-1,198.11%
TYRA	TYRA BIOSCIENCES INC	$1.65B	-35.80%	-33.60%	-39.05%	-47.60%	0.08	17.71	N/A	N/A	N/A
GNLX	GENELUX CORP	$90.94M	-129.30%	-97.40%	-160.49%	-169.50%	0.34	4.20	N/A	N/A	N/A
ORKA	ORUKA THERAPEUTICS INC	$1.60B	-25.80%	-24.80%	-20.81%	-31.60%	0.05	16.94	N/A	N/A	N/A
ENGN	ENGENE HOLDINGS INC	$639.70M	-55.50%	-46.00%	-60.32%	-54.00%	0.32	6.30	N/A	N/A	N/A
PRAX	PRAXIS PRECISION MEDICINES INC	$7.99B	-66.90%	-60.30%	-79.49%	-115.20%	0.15	5.18	100.00%	-3,658.50%	-3,658.53%
NNVC	NANOVIRICIDES INC	$15.84M	-95.80%	-83.80%	-113.25%	-138.60%	0.17	1.06	N/A	N/A	N/A
ASBP	ASPIRE BIOPHARMA HOLDINGS INC	$3.92M	N/A	-1,490.10%	158.11%	923.80%	-1.21	0.17	45.50%	-1,056,755.00%	-933,320.14%
OLMA	OLEMA PHARMACEUTICALS INC	$1.74B	-41.50%	-37.60%	-48.25%	-50.60%	0.15	8.03	N/A	N/A	N/A
DNLI	DENALI THERAPEUTICS INC	$3.09B	-46.30%	-41.00%	-51.65%	-47.40%	0.14	9.79	N/A	N/A	N/A
KOD	KODIAK SCIENCES INC	$1.22B	-246.20%	-78.40%	-123.74%	-76.50%	8.20	1.79	N/A	N/A	N/A
AGIO	AGIOS PHARMACEUTICALS INC	$1.55B	-28.40%	-26.40%	-31.29%	-28.90%	0.08	13.82	87.20%	-895.90%	-915.68%
AVIR	ATEA PHARMACEUTICALS INC	$324.23M	-38.40%	-35.90%	-45.29%	-48.10%	0.09	16.66	N/A	N/A	N/A
CMND	CLEARMIND MEDICINE INC	$2.02M	-208.10%	-70.70%	-317.50%	172.70%	4.10	1.22	N/A	N/A	N/A
RYTM	RHYTHM PHARMACEUTICALS INC	$6.91B	-445.30%	-47.70%	-42.34%	-84.70%	1.42	4.75	89.40%	-113.40%	-97.79%
PHIO	PHIO PHARMACEUTICALS CORP	$9.90M	-86.40%	-75.80%	-80.83%	960.20%	0.17	6.90	N/A	N/A	N/A
VTGN	VISTAGEN THERAPEUTICS INC	$22.24M	-90.70%	-76.20%	-92.50%	-747.70%	0.22	5.79	100.00%	-8,631.90%	-8,631.90%
QNRX	QUOIN PHARMACEUTICALS LTD	$10.48M	-334.40%	-125.20%	-2,088.80%	-453.90%	-6.29	1.04	N/A	N/A	N/A
RNTX	REIN THERAPEUTICS INC	$29.97M	-118.70%	-102.00%	-125.99%	1,317.70%	0.16	0.90	N/A	N/A	N/A
ENTX	ENTERA BIO LTD	$47.69M	-71.90%	-63.40%	-67.99%	2,206.40%	0.14	10.83	0.00%	-8,694.40%	-8,683.06%
INO	INOVIO PHARMACEUTICALS INC	$88.93M	-307.60%	-127.90%	24,665.13%	-846.50%	-9.99	0.79	100.00%	-59,281.70%	-59,281.69%
CYTK	CYTOKINETICS INC	$7.62B	N/A	-56.50%	-54.98%	-36.10%	-3.76	6.88	100.00%	-862.20%	-816.07%
GNPX	GENPREX INC	$4.99M	-891.70%	-389.10%	-1,658.99%	-18,136.00%	3.64	0.67	N/A	N/A	N/A
ACLX	ARCELLX INC	$3.93B	-51.10%	-33.10%	-46.45%	-49.00%	0.49	3.99	100.00%	-607.00%	-695.50%
IKT	INHIBIKASE THERAPEUTICS INC	$127.80M	-57.20%	-52.80%	-65.37%	-217.00%	0.09	11.73	N/A	N/A	N/A
ELAB	PMGC HOLDINGS INC	$327.41k	-82.90%	-63.50%	-70.06%	-523.90%	0.76	1.79	82.20%	458.40%	454.25%
IOVA	IOVANCE BIOTHERAPEUTICS INC	$1.00B	-55.20%	-43.10%	-51.12%	-96.30%	0.29	3.41	24.00%	-158.80%	-159.06%
ARMP	ARMATA PHARMACEUTICALS INC	$279.74M	N/A	-54.50%	63.18%	-29.50%	-1.94	0.12	100.00%	-3,797.70%	-2,580.16%
AARD	AARDVARK THERAPEUTICS INC	$275.43M	-54.90%	-37.90%	-39.82%	-58.70%	0.09	12.04	N/A	N/A	N/A
IRON	DISC MEDICINE INC	$3.01B	-31.60%	-29.00%	-29.38%	-36.40%	0.10	23.45	N/A	N/A	N/A
MAIA	MAIA BIOTECHNOLOGY INC	$72.95M	-715.10%	-199.20%	-1,249.70%	434.20%	281.75	1.18	N/A	N/A	N/A
SRRK	SCHOLAR ROCK HOLDING CORP	$4.86B	-122.00%	-86.50%	-100.33%	-144.60%	0.68	6.31	N/A	N/A	N/A
BTAI	BIOXCEL THERAPEUTICS INC	$32.80M	N/A	-185.00%	-738.28%	-61.10%	-1.50	1.18	-28.20%	-9,070.60%	-6,860.51%
CLNN	CLENE INC	$44.33M	N/A	-125.60%	-200.24%	-105.20%	-2.81	1.53	82.20%	-14,250.50%	-13,104.67%
NRIX	NURIX THERAPEUTICS INC	$1.73B	-57.50%	-43.80%	-43.83%	-59.10%	0.28	7.02	100.00%	-314.90%	-314.00%
NVCT	NUVECTIS PHARMA INC	$227.72M	-155.40%	-99.90%	-115.81%	284.60%	0.48	3.07	N/A	N/A	N/A

Biotech Stocks FAQ

What are the best biotech stocks to buy right now in Feb 2026?

According to Zen Ratings, our proprietary rating system that evaluates 115 factors proven to drive growth in stocks and assigns each stock in our system an overall letter grade as well as 7 individual Component Grades for Value, Growth, Momentum, Sentiment, Safety, Financials, and proprietary AI algorithms, the 3 best biotechnology stocks to buy right now are:

1. Biocryst Pharmaceuticals (NASDAQ:BCRX)

Biocryst Pharmaceuticals (NASDAQ:BCRX) is the #1 top biotech stock out of 610 with a Zen Rating of A. Stocks with a rating of A have had an average return of +32.52% per year. Learn more.

The Component Grade breakdown for Biocryst Pharmaceuticals (NASDAQ:BCRX) is: Value: B, Growth: A, Momentum: C, Sentiment: A, Safety: C, Financials: B, and AI: B.

Biocryst Pharmaceuticals (NASDAQ:BCRX) has a Due Diligence Score of 15, which is -9 points lower than the biotech industry average of 24. Although this number is below the industry average, our proven quant model rates BCRX as a "A".

BCRX passed 5 out of 33 due diligence checks and has weak fundamentals. Biocryst Pharmaceuticals has seen its stock lose -26.92% over the past year, overperforming other biotech stocks by 4 percentage points.

Biocryst Pharmaceuticals has an average 1 year price target of $21.86, an upside of 242.59% from Biocryst Pharmaceuticals's current stock price of $6.38.

Biocryst Pharmaceuticals stock has a consensus Buy recommendation according to Wall Street analysts. Of the 7 analysts covering Biocryst Pharmaceuticals, 28.57% have issued a Strong Buy rating, 57.14% have issued a Buy, 14.29% have issued a hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.

2. Jazz Pharmaceuticals (NASDAQ:JAZZ)

Jazz Pharmaceuticals (NASDAQ:JAZZ) is the #2 top biotech stock out of 610 with a Zen Rating of A. Stocks with a rating of A have had an average return of +32.52% per year. Learn more.

The Component Grade breakdown for Jazz Pharmaceuticals (NASDAQ:JAZZ) is: Value: A, Growth: B, Momentum: C, Sentiment: B, Safety: B, Financials: B, and AI: B.

Jazz Pharmaceuticals (NASDAQ:JAZZ) has a Due Diligence Score of 16, which is -8 points lower than the biotech industry average of 24. Although this number is below the industry average, our proven quant model rates JAZZ as a "A".

JAZZ passed 5 out of 33 due diligence checks and has weak fundamentals. Jazz Pharmaceuticals has seen its stock return 37.84% over the past year, overperforming other biotech stocks by 69 percentage points.

Jazz Pharmaceuticals has an average 1 year price target of $213.27, an upside of 28.87% from Jazz Pharmaceuticals's current stock price of $165.50.

Jazz Pharmaceuticals stock has a consensus Strong Buy recommendation according to Wall Street analysts. Of the 11 analysts covering Jazz Pharmaceuticals, 63.64% have issued a Strong Buy rating, 27.27% have issued a Buy, 9.09% have issued a hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.

3. Pharming Group Nv (NASDAQ:PHAR)

Pharming Group Nv (NASDAQ:PHAR) is the #3 top biotech stock out of 610 with a Zen Rating of A. Stocks with a rating of A have had an average return of +32.52% per year. Learn more.

The Component Grade breakdown for Pharming Group Nv (NASDAQ:PHAR) is: Value: B, Growth: B, Momentum: A, Sentiment: B, Safety: C, Financials: C, and AI: B.

Pharming Group Nv (NASDAQ:PHAR) has a Due Diligence Score of 33, which is 9 points higher than the biotech industry average of 24.

PHAR passed 10 out of 33 due diligence checks and has average fundamentals. Pharming Group Nv has seen its stock return 81.4% over the past year, overperforming other biotech stocks by 112 percentage points.

What are the biotech stocks with highest dividends?

Out of 5 biotech stocks that have issued dividends in the past year, the 3 biotech stocks with the highest dividend yields are:

1. Dominari Holdings (NASDAQ:DOMH)

Dominari Holdings (NASDAQ:DOMH) has an annual dividend yield of 26.41%, which is 21 percentage points higher than the biotech industry average of 5.56%.

Dominari Holdings's dividend payout ratio of 8.4% indicates that its high dividend yield is sustainable for the long-term.

2. Oramed Pharmaceuticals (NASDAQ:ORMP)

Oramed Pharmaceuticals (NASDAQ:ORMP) has an annual dividend yield of 7.33%, which is 2 percentage points higher than the biotech industry average of 5.56%.

Oramed Pharmaceuticals's dividend payout ratio of 0% indicates that its high dividend yield might not be sustainable for the long-term.

3. Royalty Pharma (NASDAQ:RPRX)

Royalty Pharma (NASDAQ:RPRX) has an annual dividend yield of 1.97%, which is -4 percentage points lower than the biotech industry average of 5.56%. Royalty Pharma's dividend payout is stable, having never dropped by more than 10% in the last 10 years. Royalty Pharma's dividend has shown consistent growth over the last 10 years.

Royalty Pharma's dividend payout ratio of 49.4% indicates that its dividend yield is sustainable for the long-term.

Why are biotech stocks up?

Biotech stocks were up 2.73% in the last day, and down -0.36% over the last week. Roivant Sciences was the among the top gainers in the biotechnology industry, gaining 22.14% yesterday.

Roivant Sciences shares are trading higher after the company reported better-than-expected Q3 sales results.

What are the most undervalued biotech stocks?

Based on the Valuation rating, one of the 7 components of a stocks overall Zen Ratings grade, which evaluates factors including estimated earnings yield, earnings before interest and taxes/enterprise value, cash flow yield, free cash flow to price, and price-to-earnings growth (PEG ratio), the 3 most undervalued biotech stocks right now are:

1. Harmony Biosciences Holdings (NASDAQ:HRMY)

Harmony Biosciences Holdings (NASDAQ:HRMY) is the most undervalued biotech stock based on its Valuation Rating of A. Valuation is one of 7 Component Grades used to calculate the overall Zen Rating.

Harmony Biosciences Holdings has a valuation score of 71, which is 55 points higher than the biotech industry average of 16. It passed 5 out of 7 valuation due diligence checks.

Harmony Biosciences Holdings's stock has dropped -3.89% in the past year. It has overperformed other stocks in the biotech industry by 27 percentage points.

2. Innoviva (NASDAQ:INVA)

Innoviva (NASDAQ:INVA) is the second most undervalued biotech stock based on its Valuation Rating of A. Valuation is one of 7 Component Grades used to calculate the overall Zen Rating.

Innoviva has a valuation score of 57, which is 41 points higher than the biotech industry average of 16. It passed 4 out of 7 valuation due diligence checks.

Innoviva's stock has gained 19.39% in the past year. It has overperformed other stocks in the biotech industry by 50 percentage points.

3. Incyte (NASDAQ:INCY)

Incyte (NASDAQ:INCY) is the third most undervalued biotech stock based on its Valuation Rating of A. Valuation is one of 7 Component Grades used to calculate the overall Zen Rating.

Incyte has a valuation score of 57, which is 41 points higher than the biotech industry average of 16. It passed 4 out of 7 valuation due diligence checks.

Incyte's stock has gained 44.62% in the past year. It has overperformed other stocks in the biotech industry by 75 percentage points.

Are biotech stocks a good buy now?

64.15% of biotech stocks rated by analysts are a strong buy right now. On average, analysts expect biotech stocks to rise by 67.9% over the next year.

3.35% of biotech stocks have a Zen Rating of A (Strong Buy), 6.5% of biotech stocks are rated B (Buy), 41.93% are rated C (Hold), 37.53% are rated D (Sell), and 10.69% are rated F (Strong Sell).

What is the average p/e ratio of the biotechnology industry?

The average P/E ratio of the biotechnology industry is 234.95x.

WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.

Sectors & Industries HealthcareBiotechnology
Best Biotech Stocks to Buy Now (2026)
Top biotech stocks in 2026 ranked by overall Zen Rating. "A" Rated stocks have returned an average of +32.52% per year, and are the best biotech stocks to buy now. Learn More.

Biotech Stocks FAQ

1. Biocryst Pharmaceuticals (NASDAQ:BCRX)

2. Jazz Pharmaceuticals (NASDAQ:JAZZ)

3. Pharming Group Nv (NASDAQ:PHAR)

1. Dominari Holdings (NASDAQ:DOMH)

2. Oramed Pharmaceuticals (NASDAQ:ORMP)

3. Royalty Pharma (NASDAQ:RPRX)

1. Harmony Biosciences Holdings (NASDAQ:HRMY)

2. Innoviva (NASDAQ:INVA)

3. Incyte (NASDAQ:INCY)

Company

Stock Tools

Stock Ideas

Sectors & IndustriesHealthcareBiotechnologyBest Biotech Stocks to Buy Now (2026)Top biotech stocks in 2026 ranked by overall Zen Rating. "A" Rated stocks have returned an average of +32.52% per year, and are the best biotech stocks to buy now. Learn More.

Biotech Stocks FAQ

1. Biocryst Pharmaceuticals (NASDAQ:BCRX)

2. Jazz Pharmaceuticals (NASDAQ:JAZZ)

3. Pharming Group Nv (NASDAQ:PHAR)

1. Dominari Holdings (NASDAQ:DOMH)

2. Oramed Pharmaceuticals (NASDAQ:ORMP)

3. Royalty Pharma (NASDAQ:RPRX)

1. Harmony Biosciences Holdings (NASDAQ:HRMY)

2. Innoviva (NASDAQ:INVA)

3. Incyte (NASDAQ:INCY)

Company

Stock Tools

Stock Ideas

Sectors & Industries HealthcareBiotechnology
Best Biotech Stocks to Buy Now (2026)
Top biotech stocks in 2026 ranked by overall Zen Rating. "A" Rated stocks have returned an average of +32.52% per year, and are the best biotech stocks to buy now. Learn More.